Skip to main content
Equibles
CORT logo

CORT · Corcept Therapeutics Inc

Track CORT — free

Use CORT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CORT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$114.47 +3.96 (+3.58%) At close · Aug 14
Market Cap
$12.37B
Shares
108.10M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding CORT

319 fund positions
Fund Balance Value % of Fund Open
iShares Core S&P Small-Cap ETF 5,621,049 $226,584,485 0.25%
VANGUARD TOTAL STOCK MARKET INDEX FUND 2,853,467 $115,023,255 0.01%
First Trust NYSE Arca Biotechnology Index Fund 2,150,626 $86,691,734 3.82%
VANGUARD SMALL-CAP INDEX FUND 2,084,686 $84,033,693 0.05%
Fidelity Contrafund 1,186,243 $47,817,455 0.03%
VANGUARD SMALL-CAP GROWTH INDEX FUND 1,165,399 $46,977,234 0.12%
VANGUARD EXTENDED MARKET INDEX FUND 1,045,387 $42,139,550 0.05%
Select Biotechnology Portfolio 506,746 $35,213,780 0.67%
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF 847,020 $34,143,376 0.25%
Fidelity Extended Market Index Fund 480,572 $33,394,948 0.08%
iShares S&P Small-Cap 600 Growth ETF 807,704 $32,558,548 0.50%
Schwab U.S. Small-Cap ETF 449,759 $31,253,753 0.14%
U.S. SMALL CAP PORTFOLIO 550,039 $25,587,814 0.14%
iShares Russell Mid-Cap Growth ETF 633,515 $25,536,990 0.14%
VANGUARD TAX-MANAGED SMALL-CAP FUND 615,785 $24,822,293 0.26%
VANGUARD S&P SMALL-CAP 600 INDEX FUND 323,941 $22,510,660 0.38%
Strategic Advisers Fidelity U.S. Total Stock Fund 287,496 $19,978,097 0.01%
State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF 493,859 $19,907,456 0.50%
VANGUARD HEALTH CARE INDEX FUND 284,629 $19,778,869 0.10%
Schwab U.S. Mid-Cap ETF 253,190 $17,594,173 0.12%
Strategic Advisers U.S. Total Stock Fund 251,299 $17,462,768 0.02%
VIP Mid Cap Portfolio 428,200 $17,260,742 0.22%
Fidelity Mid Cap Index Fund 348,117 $16,194,403 0.03%
iShares Russell 1000 Growth ETF 378,947 $15,275,354 0.01%
iShares Russell Mid-Cap ETF 359,976 $14,510,633 0.03%
Fidelity SAI U.S. Quality Index Fund 285,918 $13,300,905 0.05%
Dimensional U.S. Small Cap ETF 285,134 $13,264,434 0.09%
Invesco Pharmaceuticals ETF 267,966 $12,465,778 3.74%
Fidelity Total Market Index Fund 177,053 $12,303,413 0.01%
ROYCE SMALL-CAP TRUST, INC. 132,800 $11,546,960 0.44%
VANGUARD RUSSELL 1000 GROWTH INDEX FUND 155,183 $10,783,667 0.02%
iShares U.S. Pharmaceuticals ETF 261,660 $10,547,515 1.05%
Fidelity Contrafund K6 257,572 $10,382,727 0.03%
Fidelity Series Total Market Index Fund 142,976 $9,935,402 0.01%
Columbia Small Cap Index Fund 139,749 $9,711,158 0.38%
VANGUARD S&P SMALL-CAP 600 GROWTH INDEX FUND 111,336 $7,736,739 0.77%
Boston Trust Walden Small Cap Fund 178,516 $7,195,980 0.73%
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF 174,971 $7,053,081 2.29%
BlackRock Advantage Small Cap Core Fund 94,950 $6,598,076 0.13%
Schwab Fundamental U.S. Small Company ETF 91,776 $6,377,514 0.07%
Fidelity Large Cap Growth Index Fund 133,578 $6,214,049 0.01%
Janus Henderson Small/Mid Cap Growth Alpha ETF 127,990 $5,954,095 0.61%
JNL Small Cap Index Fund 145,251 $5,855,068 0.24%
F/m Emerald Life Sciences Innovation ETF 72,454 $5,034,828 4.79%
HUSSMAN STRATEGIC MARKET CYCLE FUND 120,000 $4,837,200 1.22%
iShares Core S&P Total U.S. Stock Market ETF 119,832 $4,830,428 0.01%
Fidelity Mid Cap Growth Index Fund 114,793 $4,627,306 0.14%
Dimensional U.S. Core Equity 2 ETF 99,381 $4,623,204 0.01%
Invesco S&P SmallCap Health Care ETF 65,575 $4,556,807 3.47%
U.S. CORE EQUITY 2 PORTFOLIO 97,770 $4,548,260 0.01%
Showing 1–50 of 319 positions
Key facts CIK 1088856 CUSIP 218352102 13F (30d) 390 filings 389 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)